David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Shoppers Love a Bargain, and Investors Should Love ContextLogic Stock

By David Moadel, InvestorPlace Contributor

Even while Wish's Core Marketplace revenues are expanding across multiple continents, WISH stock remains surprisingly cheap at the moment.

In Light of Surprise Profit, Tilray Is a Cannabis Go-To Holding

By David Moadel, InvestorPlace Contributor

As the bears go into hibernation, TLRY stock is on a well-deserved but nonetheless shocking journey to much higher price points.

Prepare for a Memorable Second Act with ViacomCBS

By David Moadel, InvestorPlace Contributor

For both value investors and dividend collectors, VIAC stock is more compelling than it's been in a very long time.

Palantir Technologies Stock Is the Covid-19 Play You Never Expected

By David Moadel, InvestorPlace Contributor

Palantir is known for providing analytics for government agencies. That's true, but PLTR stock offers more diversification than you'd expect.

Covid-19 Vaccine Dose Delay Spells Even More Trouble for Novavax Stock

By David Moadel, InvestorPlace Contributor

Investors might hope that the spread of the Delta variant will boost NVAX stock, but a recent news release is likely to hinder progress.

Load More